Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-06-25

Clinical Trial Update: Topical Brinzolamide Ophthalmic Suspension Versus Placebo in the Treatment of Infantile Nystagmus Syndrome [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing topical brinzolamide ophthalmic suspension to placebo in infantile nystagmus syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Brinzolamide ophthalmic suspension (brinzolamide)

Snippet

Sponsor: Akron Children's Hospital | Conditions: Infantile Nystagmus Syndrome | Phase 4 | Status: COMPLETED